On Nov. 30, 2020, Hologic announced that the FDA had approved a diagnostic claim for its HIV-1 (human immunodeficiency virus type 1) viral load monitoring assay. The Aptimaﾮ HIV-1 Quant Dx assay was the first dual-claim assay for both diagnosis and viral load monitoring in the U.S.